Improved Mortality and Haemodynamics with Milrinone in Cardiogenic Shock Due to Acute Decompensated Heart Failure

Abstract

The use of milrinone compared with dobutamine in patients with ADHF-CS is associated with lower 30 day mortality and improved haemodynamics. These findings warrant further study in future randomized controlled trials.